Subscribe To
Processa Pharmaceuticals Provides Data Update Supporting a Potential Personalized Treatment Approach for Improved Cancer Care
Interim analysis of Phase 1B data suggests Processa’s novel chemotherapy treatment could improve safety and efficacy in more patients by individualizing the dosing regimen for each patient HANOVER, MD, Aug. 17, 2023 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (Nasdaq: PCSA) (“Processa” or the “Company”), a clinical-stage pharmaceutical company focused on developing the next generation of […] The post Processa Pharmaceuticals Provides Data Update Supporting a Potential Personalized Treatmen...
Read More
Content Topics
Processa
Pharmaceuticals
Provides
Data
Update
Supporting
Potential
Personalized
Treatment
Approach
Improved
Cancer
Forex
Posted: Aug 17 2023, 12:05
Author Name: forextv
Views: 022117